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Fig. 1. A simple chest X-ray shows a 1.9x1.7 cm hyperdense, 
ovoid lesion in the lingual segment (arrow).
Lung Cancer Associated with Sarcoidosis
− A case report −
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Sarcoidosis is a somewhat common pulmonary disease, but the concurrence of lung cancer and sarcoidosis in the 
same patient is very rare. Because sarcoidosis usually presents as mediastinal lymphadenopathies, this concurrence 
in a lung cancer patient detected radiologically is apt to be misunderstood to be mediastinal metastases, and it is 
thus considered to be an unresectable disease. We report a case of lung cancer associated with sarcoidosis that 
developed in a 65-year-old woman who underwent surgery. Radiological studies revealed a 1.9x1.7 cm mass in the 
left upper lobe with multiple enlarged bilateral mediastinal lymph nodes (2R, 3a, 4R, 4L, 5, 6, 7, 8R). Pathologic 
findings showed that the mass was a well-differentiated adenocarcinoma and all of the enlarged mediastinal lymph 
nodes were granulomas without cancer metastasis. We report this case with a review of the literature.
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CASE REPORT
A  65-year-old  woman  who  had  had  a  chronic  cough  for  4 
years  and  follow-up  in  the  pulmonary  department  was  in-
cidentally discovered to have a mass in the left upper lobe of 
the  lung  on  a  simple  chest  x-ray ( F i g .  1 ) .  H e r  v i t a l  s i g n s  a t  
admission  were  normal  and  laboratory  results  were  WBC 
4,290/mm
3,  hemoglobin  12.5  g/dL,  hematocrit  37.2%,  platelet 
172  k/mm
3,  ESR  7  mm/h,  and  CEA  (carcinoembryonic  anti-
gen)  0.86  ng/mL.  A  serology  test  and  culture  for  myco-
plasma,  chlamydia,  and  tuberculosis  were  all  negative.  Chest 
computed  tomography  and  PET-CT  showed  a  1.9×1.7  cm 
mass  in  the  left  upper  lobe  and  suspicious  metastatic  lymph 
nodes  in  multiple  bilateral  mediastinal  lymph  nodes  (2R,  3a, 
4R,  4L,  5,  6,  7,  8R)  (Fig.  2).  Bronchoscopic  findings  were Jae Jun Kim, et al
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Fig. 2. Chest CT (A) and PET-CT (B, C) show a suspicious malignant tumor in the lingular segment and multiple bilateral mediastinal 
lymph node metastases. 
Fig. 3. Pathologic appearance of the resected specimen. (A) Lung tumor: a well-differentiated adenocarcinoma was found. (B) Lymph node: 
a noncaseating epithelioid cell granuloma but no cancer metastasis was observed (H&E stain, ×200).
non-specific  and  PCNA  (percutaneous  needle  aspiration)  of 
the  mass  under  chest  CT  revealed  adenocarcinoma.  At  first 
we  considered  it  an  unresectable  lung  cancer  with  con-
tralateral  metastatic  mediastinal  lymph  nodes  (N3).  We  biop-
sied  the  right  paratracheal  lymph  nodes  (2R,  4R)  under  me-
diastinoscopy  and  the  pathology  reports  showed  that  they 
were  benign  and  non-caseous  granuloma.  We  chose  to  oper-
ate  and  performed  a  thoracotomy  for  a  left  upper  lobectomy 
and  mediastinal  lymph  node  dissection.  After  the  operation, 
the  pathology  report  showed  that  the  mass  was  adenocar-
cinoma  and  there  was  no  cancer  metastasis  in  the  dissected 
lymph  nodes  with  the  exception  of  noncaseating  epithelioid 
cell  granuloma  (Fig.  3)  that  was  consistent  with  sarcoidosis. 
The  tuberculosis  polymerase  chain  reaction  (Tb-PCR)  test 
from the specimens was negative. The stage was estimated to 
be  IB  (T2N0M0).  The  patient  was  discharged  on  the  sixth 
postoperative  day  without  any  complications.
DISCUSSION
Curative  resection  for  lung  cancer  is  difficult  when  the 
cancer  has  metastasized  to  the  mediastinal  lymph  nodes.  To Lung Cancer with Sarcoidosis
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determine  the  optimal  treatment  strategy,  especially  in-
dications  for  surgery,  mediastinal  lymph  nodes  must  be  eval-
uated  pathologically  before  the  operation.  There  are  many 
reasons why mediastinal lymphadenopathy may look like can-
cer  metastases  radiologically,  and  one  of  them  is  sarcoidosis 
[1]. 
Sarcoidosis  is  a  systemic  granulomatous  disease  of  un-
known  etiology  that  mainly  develops  between  25  and  40 
years  of  age  and  primarily  affects  the  lungs  and  the  lym-
phatic  system  [1,2].  The  generally  accepted  pathogenic  hy-
pothesis  is  that  certain  environmental  factors  could  promote 
sarcoidosis in genetically susceptible hosts [2]. The character-
istic  lesion  of  sarcoidosis  is  a  noncaseating  granuloma  that 
consists  of  epithelioid  cells  and  T  lymphocytes  [2].  Diverse 
clinical  courses  are  observed  according  to  the  epidemiologic 
factors,  involved  organs,  and  disease  severity  [2].  Spontane-
ous  remissions  occur  in  about  two  thirds  of  patients,  but  the 
clinical  course  is  chronic  or  progressive  in  10  to  30%. 
M o r t a l i t y ,  r a n g i n g  b e t w e e n  1  a n d  5 % ,  i s  m o s t l y  r e l a t e d  t o  
progressive  respiratory  failure,  the  central  nervous  system,  or 
myocardial  involvement  [2,3].  The  mainstay  of  treatment  for 
sarcoidosis is systemic corticosteroid administration [2]. How-
ever,  the  indication,  optimal  dose,  and  duration  of  cortico-
steroid  therapy  continue  to  be  controversial  [1,2].
The  association  of  sarcoidosis  with  malignancy  has  been 
published  in  several  studies  with  conflicting  results,  due  to 
the  clinical  and  radiographic  features  of  the  disease,  which 
may  be  similar  to  malignancies  such  as  lymphoma  or  lung 
cancer,  sometimes  lacking  histologic  confirmation  [4,5].  The 
relationship  between  sarcoidosis  and  lung  cancer  has  been 
published  in  several  studies.  Brincker  and  Wilbek  studied 
2,544  patients  and  found  that  lung  cancer  occurred  3  times 
more frequently in patients with sarcoidosis [5,6], but the ex-
act  relationship  between  sarcoid o s i s  a n d  l u n g  c a n c e r  i s  s t i l l  
u n c l e a r  [ 5 ] .  S a k u l a  p r e s e n t e d  3  p ossibilities:  (1)  sarcoidosis 
develops  before  the  development  of  the  lung  cancer,  and  is 
more  or  less  related  and  may  even  induce  the  malignant 
change;  (2)  sarcoidosis  develops  as  a  reaction  to  the  lung 
cancer;  (3)  sarcoidosis  develops  before  the  development  of 
the lung cancer, the occurrence of the lung cancer and sarcoi-
dosis  being  completely  coincidenta l  [ 7 ] .  S a k u l a ’ s  1 s t  t y p e  i s  
represented  by  cancer  that  develops  from  postinflammatory 
scar tissue, in other words, scar cancer. The 2nd type is diffi-
cult  to  apply  because  one  cannot  know  exactly  when  sarcoi-
dosis  developed  before  it  is  clinically  apparent  [6].  In  our 
case,  sarcoidosis  and  lung  cancer  occurred  simultaneously, 
there was no sarcoidosis in the lung mass and no scar lesion. 
This  case  was  the  3rd  of  Sakula’s  types.  Despite  there  cur-
rently  being  conclusive  evidence,  sarcoidosis  is  suggested  to 
have  no  influence  on  the  prognosis  of  such  patients  [3,6]. 
Several  cases  with  concurrent  sarcoidosis  and  lung  cancer 
h a v e  b e e n  r e p o r t e d .  I n  m o s t  o f  these  cases,  sarcoidosis  ex-
isted  for  multiple  years  before  the  development  of  lung 
cancer.  Simultaneous  diagnosis  of  both  diseases,  as  in  our 
case,  is  rarer. 
We  found  and  treated  the  patient  with  coincidence  of  sar-
coidosis  and  lung  cancer  successfully.
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